Happel David — SEC Form 4 filings
SEC reporting owner CIK 1623567. 7 Form 4 filings on record with FilingPulse; latest filed 2026-07-22.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-03-28 to 2026-07-22. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 12,100 shares, $63,731 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 3 legs across 3 filings — 141,630 shares, $1,160,048 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 5.
- Largest priced transaction: sale of 65,478 shares @ $9.13 ($598,115) in Sagimet Biosciences Inc., filed 2025-07-23.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Sagimet Biosciences Inc. (SGMT) | President & CEO, Director | 7 | 1 leg · 12,100 sh · $63,731 | 3 legs · 141,630 sh · $1,160,048 | 5 |
Form 4 filings — Happel David
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-22 | 4 | Sagimet Biosciences Inc. (SGMT) | Sale (S): 64,051 @ $7.76 | EDGAR |
| 2026-06-01 | 4 | Sagimet Biosciences Inc. (SGMT) | Grant/award (A): 300,000 (derivative) @ $0 | EDGAR |
| 2026-02-20 | 4 | Sagimet Biosciences Inc. (SGMT) | Grant/award (A): 128,000 @ $0 · Grant/award (A): 256,000 (derivative) @ $0 | EDGAR |
| 2026-02-12 | 4 | Sagimet Biosciences Inc. (SGMT) | Sale (S): 12,101 @ $5.36 | EDGAR |
| 2025-07-23 | 4 | Sagimet Biosciences Inc. (SGMT) | Sale (S): 65,478 @ $9.13 | EDGAR |
| 2025-02-07 | 4 | Sagimet Biosciences Inc. (SGMT) | Grant/award (A): 116,000 @ $0 · Grant/award (A): 472,000 (derivative) @ $0 | EDGAR |
| 2024-03-28 | 4 | Sagimet Biosciences Inc. (SGMT) | Purchase (P): 12,100 @ $5.27 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1623567 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →